ANTIGENS PROTECTIVE AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS

This invention relates to antigenic polypeptides or peptide fragments or variants thereof suitable for use in vaccines to protect hosts susceptible to infection by Echinococcus or Taeniid parasites, particularly infection by E. granulosus. The antigens are preferably obtained by expression of DNA co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HEATH, DAVID, DUNCAN, RALSTON, MARK, JOHN, LAWRENCE, STEPHEN, BRUCE, MAASS, DAVID, RICHARD, LIGHTOWLERS, MARSHALL, WILLIAM
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HEATH, DAVID, DUNCAN
RALSTON, MARK, JOHN
LAWRENCE, STEPHEN, BRUCE
MAASS, DAVID, RICHARD
LIGHTOWLERS, MARSHALL, WILLIAM
description This invention relates to antigenic polypeptides or peptide fragments or variants thereof suitable for use in vaccines to protect hosts susceptible to infection by Echinococcus or Taeniid parasites, particularly infection by E. granulosus. The antigens are preferably obtained by expression of DNA coding therefor in a recombinant host cell. The antigenic polypeptide of the invention includes the amino acid sequence of Figure 4. Cette invention concerne des polypeptides antigéniques ou des fragments de peptides ou leurs variants, utilisables dans des vaccins pour protéger les porteurs susceptibles d'être infectés par les parasites Echinococcus ou Taeniid, notamment l'Echinococcus granulosus. De préférence, les antigènes sont obtenus par l'expression de l'ADN codant pour cela dans une cellule porteuse recombinante. Le polypeptide antigénique selon cette invention comprend la séquence d'acide aminé de la figure 4.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO9316722A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO9316722A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO9316722A13</originalsourceid><addsrcrecordid>eNqNjDEKwkAQRbexEPUOcwGLJKBYDuNmd0BmJLublCGEtRINxPtjBO2t3i_ef2szokR2VgJcG42WIrcW0CFLiGDJsygpUQrgGpR00bBMlvpjqgDKGVokYrEBSCUuRxYHIZGHX3prVrfhPufdlxsDtY3k93l69nmehjE_8qvv9FQVh2NZYlH9obwB_Uo0cg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIGENS PROTECTIVE AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS</title><source>esp@cenet</source><creator>HEATH, DAVID, DUNCAN ; RALSTON, MARK, JOHN ; LAWRENCE, STEPHEN, BRUCE ; MAASS, DAVID, RICHARD ; LIGHTOWLERS, MARSHALL, WILLIAM</creator><creatorcontrib>HEATH, DAVID, DUNCAN ; RALSTON, MARK, JOHN ; LAWRENCE, STEPHEN, BRUCE ; MAASS, DAVID, RICHARD ; LIGHTOWLERS, MARSHALL, WILLIAM</creatorcontrib><description>This invention relates to antigenic polypeptides or peptide fragments or variants thereof suitable for use in vaccines to protect hosts susceptible to infection by Echinococcus or Taeniid parasites, particularly infection by E. granulosus. The antigens are preferably obtained by expression of DNA coding therefor in a recombinant host cell. The antigenic polypeptide of the invention includes the amino acid sequence of Figure 4. Cette invention concerne des polypeptides antigéniques ou des fragments de peptides ou leurs variants, utilisables dans des vaccins pour protéger les porteurs susceptibles d'être infectés par les parasites Echinococcus ou Taeniid, notamment l'Echinococcus granulosus. De préférence, les antigènes sont obtenus par l'expression de l'ADN codant pour cela dans une cellule porteuse recombinante. Le polypeptide antigénique selon cette invention comprend la séquence d'acide aminé de la figure 4.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; COMPOSITIONS THEREOF ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>1993</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19930902&amp;DB=EPODOC&amp;CC=WO&amp;NR=9316722A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19930902&amp;DB=EPODOC&amp;CC=WO&amp;NR=9316722A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HEATH, DAVID, DUNCAN</creatorcontrib><creatorcontrib>RALSTON, MARK, JOHN</creatorcontrib><creatorcontrib>LAWRENCE, STEPHEN, BRUCE</creatorcontrib><creatorcontrib>MAASS, DAVID, RICHARD</creatorcontrib><creatorcontrib>LIGHTOWLERS, MARSHALL, WILLIAM</creatorcontrib><title>ANTIGENS PROTECTIVE AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS</title><description>This invention relates to antigenic polypeptides or peptide fragments or variants thereof suitable for use in vaccines to protect hosts susceptible to infection by Echinococcus or Taeniid parasites, particularly infection by E. granulosus. The antigens are preferably obtained by expression of DNA coding therefor in a recombinant host cell. The antigenic polypeptide of the invention includes the amino acid sequence of Figure 4. Cette invention concerne des polypeptides antigéniques ou des fragments de peptides ou leurs variants, utilisables dans des vaccins pour protéger les porteurs susceptibles d'être infectés par les parasites Echinococcus ou Taeniid, notamment l'Echinococcus granulosus. De préférence, les antigènes sont obtenus par l'expression de l'ADN codant pour cela dans une cellule porteuse recombinante. Le polypeptide antigénique selon cette invention comprend la séquence d'acide aminé de la figure 4.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>COMPOSITIONS THEREOF</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1993</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKwkAQRbexEPUOcwGLJKBYDuNmd0BmJLublCGEtRINxPtjBO2t3i_ef2szokR2VgJcG42WIrcW0CFLiGDJsygpUQrgGpR00bBMlvpjqgDKGVokYrEBSCUuRxYHIZGHX3prVrfhPufdlxsDtY3k93l69nmehjE_8qvv9FQVh2NZYlH9obwB_Uo0cg</recordid><startdate>19930902</startdate><enddate>19930902</enddate><creator>HEATH, DAVID, DUNCAN</creator><creator>RALSTON, MARK, JOHN</creator><creator>LAWRENCE, STEPHEN, BRUCE</creator><creator>MAASS, DAVID, RICHARD</creator><creator>LIGHTOWLERS, MARSHALL, WILLIAM</creator><scope>EVB</scope></search><sort><creationdate>19930902</creationdate><title>ANTIGENS PROTECTIVE AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS</title><author>HEATH, DAVID, DUNCAN ; RALSTON, MARK, JOHN ; LAWRENCE, STEPHEN, BRUCE ; MAASS, DAVID, RICHARD ; LIGHTOWLERS, MARSHALL, WILLIAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO9316722A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1993</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>COMPOSITIONS THEREOF</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>HEATH, DAVID, DUNCAN</creatorcontrib><creatorcontrib>RALSTON, MARK, JOHN</creatorcontrib><creatorcontrib>LAWRENCE, STEPHEN, BRUCE</creatorcontrib><creatorcontrib>MAASS, DAVID, RICHARD</creatorcontrib><creatorcontrib>LIGHTOWLERS, MARSHALL, WILLIAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HEATH, DAVID, DUNCAN</au><au>RALSTON, MARK, JOHN</au><au>LAWRENCE, STEPHEN, BRUCE</au><au>MAASS, DAVID, RICHARD</au><au>LIGHTOWLERS, MARSHALL, WILLIAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIGENS PROTECTIVE AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS</title><date>1993-09-02</date><risdate>1993</risdate><abstract>This invention relates to antigenic polypeptides or peptide fragments or variants thereof suitable for use in vaccines to protect hosts susceptible to infection by Echinococcus or Taeniid parasites, particularly infection by E. granulosus. The antigens are preferably obtained by expression of DNA coding therefor in a recombinant host cell. The antigenic polypeptide of the invention includes the amino acid sequence of Figure 4. Cette invention concerne des polypeptides antigéniques ou des fragments de peptides ou leurs variants, utilisables dans des vaccins pour protéger les porteurs susceptibles d'être infectés par les parasites Echinococcus ou Taeniid, notamment l'Echinococcus granulosus. De préférence, les antigènes sont obtenus par l'expression de l'ADN codant pour cela dans une cellule porteuse recombinante. Le polypeptide antigénique selon cette invention comprend la séquence d'acide aminé de la figure 4.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_WO9316722A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title ANTIGENS PROTECTIVE AGAINST ECHINOCOCCUS GRANULOSUS INFECTION AND VACCINES CONTAINING SUCH ANTIGENS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T13%3A23%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HEATH,%20DAVID,%20DUNCAN&rft.date=1993-09-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO9316722A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true